DNMT3B Antibody - middle region

Referencia ARP49124_P050-25UL

embalaje : 25ul

Marca : Aviva Systems Biology

Contact local distributor :


Teléfono : +1 850 650 7790

DNMT3B Antibody - middle region (ARP49124_P050)

Datasheets/ManualsPrintable datasheet for anti-DNMT3B (ARP49124_P050) antibody
Product Info
Tested Species ReactivityHuman, Mouse
Predicted Species ReactivityHuman, Mouse, Rat, Cow, Dog, Guinea Pig, Horse, Rabbit, Zebrafish
Product FormatLiquid. Purified antibody supplied in 1x PBS buffer with 0.09% (w/v) sodium azide and 2% sucrose.
ClonalityPolyclonal
HostRabbit
ApplicationWB
Reconstitution and StorageFor short term use, store at 2-8C up to 1 week. For long term storage, store at -20C in small aliquots to prevent freeze-thaw cycles.
ImmunogenThe immunogen is a synthetic peptide directed towards the middle region of human DNMT3B
PurificationAffinity Purified
Predicted Homology Based on Immunogen SequenceCow: 100%; Dog: 100%; Guinea Pig: 100%; Horse: 100%; Human: 100%; Mouse: 100%; Rabbit: 100%; Rat: 100%; Zebrafish: 100%
Peptide SequenceSynthetic peptide located within the following region: GTGRLFFEFYHLLNYSRPKEGDDRPFFWMFENVVAMKVGDKRDISRFLEC
Concentration0.5 mg/ml
Blocking PeptideFor anti-DNMT3B (ARP49124_P050) antibody is Catalog # AAP49124 (Previous Catalog # AAPY02321)
Sample Type Confirmation

DNMT3B is supported by BioGPS gene expression data to be expressed in OVCAR3

ReferenceBoland,M.J. (2008) J. Mol. Biol. 379 (3), 492-504
Gene SymbolDNMT3B
Gene Full NameDNA (cytosine-5-)-methyltransferase 3 beta
Alias SymbolsICF, ICF1, M.HsaIIIB
NCBI Gene Id1789
Protein NameDNA (cytosine-5)-methyltransferase 3B
Description of TargetDNMT3B is required for genome wide de novo methylation and is essential for the establishment of DNA methylation patterns during development. DNA methylation is coordinated with methylation of histones. DNMT3B may preferentially methylate nucleosomal DNA within the nucleosome core region. DNMT3B may function as transcriptional co-repressor by associating with CBX4 and independently of DNA methylation. DNMT3B seems to be involved in gene silencing. In association with DNMT1 and via the recruitment of CTCFL/BORIS, DNMT3B is involved in activation of BAG1 gene expression by modulating dimethylation of promoter histone H3 at H3K4 and H3K9. CpG methylation is an epigenetic modification that is important for embryonic development, imprinting, and X-chromosome inactivation. Studies in mice have demonstrated that DNA methylation is required for mammalian development. This gene encodes a DNA methyltransferase which is thought to function in de novo methylation, rather than maintenance methylation. The protein localizes primarily to the nucleus and its expression is developmentally regulated. Mutations in this gene cause the immunodeficiency-centromeric instability-facial anomalies (ICF) syndrome. Six alternatively spliced transcript variants have been described. The full length sequences of variants 4 and 5 have not been determined.
Uniprot IDQ9UBC3-3
Protein Accession #NP_787045
Nucleotide Accession #NM_175849
Protein Size (# AA)770
Molecular Weight86kDa
Protein InteractionsRBBP7; RBBP4; HDAC2; HDAC1; CHD4; MTA2; MTA1; POLR2H; POLR2C; POLR2A; DNMT1; LEO1; CDC73; PAF1; RTF1; CTR9; NRIP1; EZH2; DNMT3L; SUZ12; SIRT1; EED; UBC; EPHB1; CREB1; CBX5; TRIM28; ZFP57; UHRF2; UHRF1; MAP1LC3B; UBE2W; PLEKHJ1; DUSP23; CMTM6; PAM16; TSC22